Clinical studies recruiting near Grenoble

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Grenoble University Hospital · Nantes University Hospital · NCT05856565 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · The Lymphoma Academic Research Organisation · NCT07018752 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU Grenoble · Fondation Hôpital Saint-Joseph · NCT05674994 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · HCE · Princess Maxima Center for Pediatric Oncology · NCT05327894 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · Groupe Hospitalier Mutualiste de Grenoble · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · CHU de Grenoble-Alpes, Boulevard de la Chantourne · Lumara Bio Oncologics GmbH · NCT05706129 PulseSelect™ PFA Global Registry
Phase N/A · Centre Hospitalier Universitaire de Grenoble - Site Nord · Medtronic Cardiac Ablation Solutions · NCT06393920 Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1
Phase 1 · CHU Grenoble Aples · University Hospital, Grenoble · NCT03570450 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Hôpital Michallon · Hospices Civils de Lyon · NCT03593317 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Grenoble University Hospital · Poitiers University Hospital · NCT05686850 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Bristol-Myers Squibb · NCT07291076 Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · CHU Grenoble · Nantes University Hospital · NCT06244433 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital Michallon · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Service hématologie CHU Grenoble · University Hospital, Clermont-Ferrand · NCT04935684 Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in Hi
Phase 1/Phase 2 · CHU Grenoble Service Maladies infectieuses et tropicales · Hospices Civils de Lyon · NCT06306014 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centre Hospitalier Universitaire de Grenoble - Hopital Nord · Amgen · NCT07037433 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · NovoCure Ltd. · NCT06924099 Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis
NA · Clinique Universitaire de Rhumatologie · Centre Hospitalier Universitaire de Saint Etienne · NCT05571514 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · AbbVie · NCT06109272 Anesthesia sTrategy foR Organ Procurement In braiN dEath
Phase 3 · CHU Grenoble Alpes · University Hospital, Grenoble · NCT07166991 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · The Lymphoma Academic Research Organisation · NCT06006117 DECIdE, Shared DECIsion in hEalth : the Real-life Impact Study
NA · Département de Médecine Générale, UFR Médecine, Université G · University Hospital, Clermont-Ferrand · NCT06052917 Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children
Phase N/A · Pediatric Surgery Service, University Hospital, Grenoble · University Hospital, Tours · NCT03772119 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Merz Therapeutics GmbH · NCT07018700 High Intensity Interval Training Versus Moderate Intensity Continuous Training in Frail Elderly
Phase N/A · University Grenoble alpes · University Hospital, Grenoble · NCT07211334 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Centre Hospitalier Universitarie Grenoble Alpes (Chuga) · Turning Point Therapeutics, Inc. · NCT03093116 Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Phase 2 · The Lymphoma Academic Research Organisation · NCT06271057 Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Phase 1/Phase 2 · CHU GRENOBLE ALPES - Hôpital COUPLE ENFANT · Centre Oscar Lambret · NCT05384821

Look up another city

Look up another condition